inhaled alpha-1 antitrypsin
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for inhaled alpha-1 antitrypsin, covering 2011-07-14 to 2019-11-29. Get the full timeline:
Most recent: Clinical Trial Update: International Study Evaluating the Safety and Efficacy of Inhaled, Human, Alpha-1 Antitrypsin (AAT) in Alpha-1 Antitrypsin Deficient Patients With Emphysema [Phase 2, Phase 3]